DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pneumovax (Pneumococcal Vaccine Polyvalent) - Current Clinical Trials

 
 



Pneumovax Related Clinical Trials

Systems Biology of PNEUMOVAX�23 and PREVNAR 13� [Active, not recruiting]

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 [Completed]

A Study to Compare the Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in Healthy Volunteers (V114-002) [Completed]

Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients [Not yet recruiting]

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants [Recruiting]

Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients [Recruiting]

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease [Completed]

Effect of Obesity on Immune Response to Pneumovax 23 [Not yet recruiting]

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Completed]

Pneumococcal Vaccine in Untreated CLL Patients [Recruiting]

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) [Completed]

Pneumococcal Conjugate Vaccine Followup [Completed]

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines [Completed]

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae [Completed]

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Completed]

Polysaccharide Antibody Response Study [Not yet recruiting]

Pneumococcal Adult-dose Ranging Immunization Study [Completed]

Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) [Completed]

A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria [Completed]

Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children [Completed]

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) [Completed]

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses [Recruiting]

13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study [Completed]

Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® [Enrolling by invitation]

Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13® [Completed]

PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits [Completed]

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) [Completed]

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. [Completed]

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults [Completed]

Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults [Recruiting]

Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A [Completed]

Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease [Recruiting]

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. [Completed]

Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children [Recruiting]

Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center [Active, not recruiting]

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil [Completed]

Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers [Completed]

Protection Against Pneumococcal Infection in Children With T1DM [Recruiting]

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine [Completed]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Completed]

Evaluation of Pneumococcal Vaccine Formulations in Young Adults [Completed]

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants [Completed]

PCV13 + Hepatitis A Vaccine for Adults [Not yet recruiting]

Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. [Completed]

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD [Recruiting]

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response [Not yet recruiting]

Study to Compare Pediacel� to Infanrix�-IPV+Hib When Both Are Co-Administered With Prevenar� in Infants and Toddlers [Completed]

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali [Completed]

13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants. [Completed]

Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life [Enrolling by invitation]

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age [Completed]

Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine [Completed]

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Completed]

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants [Completed]

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam [Recruiting]

Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China [Completed]

Effect of Two Versus Three Pneumococcal Conjugate Vaccinations [Completed]

Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort [Completed]

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) [Completed]

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis [Completed]

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age [Completed]

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A [Completed]

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants [Completed]

Pneumococcal Reference Standard [Completed]

Targeting of Immune Response After Pneumococcal Vaccination [Completed]

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines [Active, not recruiting]

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose. [Completed]

Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar [Completed]

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults [Completed]

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Not yet recruiting]

Pneumococcal Vaccines Early and in Combination [Recruiting]

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults. [Completed]

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age [Completed]

Prevenar13 Post Market Surveillance [Active, not recruiting]

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older [Completed]

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Completed]

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Completed]

Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization [Completed]

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. [Completed]

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017